Search research articles
Contact Us
Filters
Showing results (201-210 of 212) with videos related to
Page
of 22
Sort By:
Gut
|
January 30, 2020
TGF-β2 silencing to target biliary-derived liver diseases
Anne Dropmann, Steven Dooley, Bedair Dewidar, et al.
Gastroenterology
|
July 31, 2019
ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice
Weiguo Fan, Tianhui Liu, Wen Chen, et al.
JHEP Reports : Innovation in Hepatology
|
July 17, 2025
ECM1 expression in chronic liver disease: Regulation by EGF/STAT1 and IFNγ/NRF2 signalling
Yujia Li, Chenjun Huang, Weiguo Fan, et al.
Archives of Toxicology
|
June 25, 2016
Gene network activity in cultivated primary hepatocytes is highly similar to diseased mammalian liver tissue
Patricio Godoy, Agata Widera, Wolfgang Schmidt-Heck, et al.
Gut
|
March 25, 2017
BMP-9 interferes with liver regeneration and promotes liver fibrosis
Katja Breitkopf-Heinlein, Christoph Meyer, Courtney König, et al.
Journal of Hepatology
|
February 4, 2015
Submassive hepatic necrosis distinguishes HBV-associated acute on chronic liver failure from cirrhotic patients with acute decompensation
Hai Li, Qiang Xia, Bo Zeng, et al.
Hepatology (Baltimore, Md.)
|
August 26, 2021
Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failure
Tao Lin, Shanshan Wang, Stefan Munker, et al.
Hepatology (Baltimore, Md.)
|
November 3, 2025
Erratum: Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failure
Tao Lin, Shanshan Wang, Stefan Munker, et al.
Progress in Molecular Biology and Translational Science
|
August 25, 2022
Evolution of biomarker research in autoimmunity conditions for health professionals and clinical practice
Arthur Silverstein, Anton Dudaev, Maria Studneva, et al.
Signal Transduction and Targeted Therapy
|
August 17, 2025
NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts
Josep Amengual, Ester Gonzalez-Sanchez, Mariana Yáñez-Bartolome, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 212) with videos related to
Sort By:
Page
of 22
Gut
|
January 30, 2020
TGF-β2 silencing to target biliary-derived liver diseases
Anne Dropmann, Steven Dooley, Bedair Dewidar, et al.
Gastroenterology
|
July 31, 2019
ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice
Weiguo Fan, Tianhui Liu, Wen Chen, et al.
JHEP Reports : Innovation in Hepatology
|
July 17, 2025
ECM1 expression in chronic liver disease: Regulation by EGF/STAT1 and IFNγ/NRF2 signalling
Yujia Li, Chenjun Huang, Weiguo Fan, et al.
Archives of Toxicology
|
June 25, 2016
Gene network activity in cultivated primary hepatocytes is highly similar to diseased mammalian liver tissue
Patricio Godoy, Agata Widera, Wolfgang Schmidt-Heck, et al.
Gut
|
March 25, 2017
BMP-9 interferes with liver regeneration and promotes liver fibrosis
Katja Breitkopf-Heinlein, Christoph Meyer, Courtney König, et al.
Journal of Hepatology
|
February 4, 2015
Submassive hepatic necrosis distinguishes HBV-associated acute on chronic liver failure from cirrhotic patients with acute decompensation
Hai Li, Qiang Xia, Bo Zeng, et al.
Hepatology (Baltimore, Md.)
|
August 26, 2021
Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failure
Tao Lin, Shanshan Wang, Stefan Munker, et al.
Hepatology (Baltimore, Md.)
|
November 3, 2025
Erratum: Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failure
Tao Lin, Shanshan Wang, Stefan Munker, et al.
Progress in Molecular Biology and Translational Science
|
August 25, 2022
Evolution of biomarker research in autoimmunity conditions for health professionals and clinical practice
Arthur Silverstein, Anton Dudaev, Maria Studneva, et al.
Signal Transduction and Targeted Therapy
|
August 17, 2025
NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts
Josep Amengual, Ester Gonzalez-Sanchez, Mariana Yáñez-Bartolome, et al.
Page
of 22